Dr. Miller uses brain imaging techniques including PET and fMRI to study the neurobiology of depression, and to identify predictors of treatment outcome with standardized treatments, including cognitive behavioral therapy.
His primary research interest involves using brain imaging techniques including neuroreceptor quantification via PET as well as fMRI to predict treatment outcome with standardized treatments for major depressive disorder.
The long-term goal of this work is to develop biomarkers that would allow clinicians to select treatments for patients suffering from depression based on the likelihood of response in individual patients.
Publications